Related Experiment Video

Updated: Aug 23, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Immunotherapy of ovarian cancer with antibodies: a focus on oregovomab

Jonathan S Berek1

  • 1David Geffen School of Medicine at UCLA, 24-137 UCLA Center for the Health Sciences, 10833 Le Conte Avenue, Los Angeles, CA 90095-1740, USA. jberek@mednet.ucla.edu

Expert Opinion on Biological Therapy
|July 23, 2004
PubMed

Insights

Oregovomab, a novel immunotherapy, shows promise in treating ovarian cancer by targeting the CA125 antigen. This antibody may help prolong remission times for patients with advanced ovarian cancer.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Advances in cancer immunology and molecular biology are driving progress in cancer immunotherapies.
  • Oregovomab is a murine monoclonal antibody targeting the ovarian cancer-associated antigen CA125.

Purpose of the Study:

  • To evaluate the efficacy of Oregovomab as an adjuvant immunotherapy for ovarian cancer.
  • To establish Oregovomab's potential to prolong remission in advanced ovarian cancer patients.

Main Methods:

  • Oregovomab targets CA125, forming immune complexes that trigger a cellular immune response against ovarian cancer.
  • Clinical trials are investigating Oregovomab's activity in post-chemotherapy and recurrent disease settings.

Main Results:

  • Oregovomab demonstrates activity in both initial chemotherapy and recurrent ovarian cancer settings.
  • Phase III trials are underway to confirm its efficacy in prolonging time to relapse.

Conclusions:

  • Oregovomab shows potential as a new adjuvant treatment for ovarian cancer.
  • Ongoing studies explore antigen processing and combination chemo-immunotherapy with Oregovomab.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...